Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
MYL SLXP AKRX MNTA Real Estate Airlines Outsourcing Action Alerts 
United States  USA  |  Create Portfolios


Processing
Collecting data for AKRX

Akorn quote and profile

 
 Companies |  Insiders  | Dashboard  
     
14.5
  
STOCK
0.00  No Change   0.00%  
Year To Date
11.1916.87
May 20 2013 

Diversification Suggestion

Use Akorn to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment
Analyze Akorn Inc Trend or Check current 30 days Akorn correlation with market (S&P 500)
1 Month Beta 1.79  
Highest Price:  
Lowest Price:  
15.36  
14.0  
May 03 2013 
May 09 2013 
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Akorn will likely underperform.
Akorn Inc Large BetaAkorn Inc Beta Legend
AKRX United States Nasdaq
Akorn Inc
Healthcare
Drugs - Generic
http://www.akorn.com
Contact Number: 847. 279. 6100
Currency: USD - US Dollar
Traded on NASDAQ
    
Current Valuation1.44 B
Shares Outstanding95.92 M
Number of Shares Shorted12.38 M
Revenue256.16 M
 United States Russel   1.11 % Macroaxis: change 1.11 Moved Up  
 
 United States SP 500   1.03 % Macroaxis: change 1.03 Moved Up  
 
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States NYSE   0.92 % Macroaxis: 0.92 Moved Up  
 
 thisGreen AKRX AKRX agains markets  0.00 % No Change  
Compare to Competition Get Alpha   Get Advice

Akorn Leadership

Rajat Rai CEO
John Kapoor Chairman of the Board, Ph.D
Bruce Kutinsky President - Consumer Health Division, Ph.D
Timothy Dick CFO and Principal Accounting Officer

Akorn Price and Market Media

The median price of Akorn for the period between Sat, Apr 20, 2013 and Mon, May 20, 2013 is 14.69 with a coefficient of variation of 2.71. The daily time series for the period is distributed with a sample standard deviation of 0.4, arithmetic mean of 14.65, and mean deviation of 0.33. The Stock received some media coverage during the period.
Akorn         Market
Price Growth (%)
 
1
Akorn Inc. stocks tumble after disappointing Q1 earnings rel...05/08/2013Macroaxis: News

Akorn Summary

Akorn Inc [AKRX] is traded on NASDAQ in USA. It is located in Akorn, Inc.Lake Forest, IL and employs 759 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.41 B. Akorn Inc conducts business under Healthcare sector and is part of Drugs - Generic industry. This company has 95.92 M outstanding shares of which 12.38 M shares are presently shorted by private and institutional investors with about 19.3 trading days to cover.
Akorn, Inc. engages in the manufacture and marketing of diagnostic and therapeutic ophthalmic pharmaceuticals products, hospital drugs, and injectable pharmaceuticals in the United States and internationally. more
Past Market
Over 30
Days
0
Out Of
100
 
Chance of
Less
Than
%
 
Follow Akorn with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Akorn to your reader
 

Akorn Research Report

Akorn vs. Mylan

Correlation analysis and fundamentals comparison between Akorn Inc and Mylan Inc

Akorn Executives

Timothy Dick CFO and Principal Accounting Officer
Bruce PharmD COO

Akorn Directors

Adrienne Graves Independent Director, Ph.D
Ronald Johnson Independent Director
Steven Meyer Independent Director
Kenneth Abramowitz Independent Director
Brian Tambi Director

Akorn Management

Mark Silverberg Executive VP, Operations, Global Quality Assurance and Regulatory Affairs
Joseph Bonaccorsi Sr. VP, General Counsel and Secretary

Akorn Fundamentals

Current Valuation vs Earnings Per Share
Number of Employees vs Price to Book
Current Valuation vs Profit Margin
Price to Sales vs Price to Book

Akorn vs Competition

Akorn vs. Mylan Inc
Akorn vs. Salix Pharmaceuticals Ltd
Akorn vs. Momenta Pharmaceuticals Inc
Akorn vs. Ligand Pharmaceuticals Incorporated
Akorn vs. Hi Tech Pharmacal Co Inc
Akorn vs. Avanir Pharmaceuticals Inc
Akorn vs. Supernus Pharmaceuticals Inc
Akorn vs. Health Enhancement Products Inc
Akorn vs. Catalyst Pharmaceutical Partners Inc

Akorn May 20 2013 Opportunity Range

Downside Deviation3.46
Information Ratio(0.17)
Maximum Drawdown9.99
Value At Risk(2.39)
Potential Upside2.45

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium